Several studies showed the CCL20-CCR6 axis was associated with several cancers, including hepatocellular carcinoma [36, 37], colorectal cancer [38, 39], breast cancer [40,41], and kidney cancer [42]. This evidence concerns the gene CCL20 and kidney cancer.